Thursday, December 4, 2025 ~ BREAKOUT SESSION
POSTER PRESENTATION SESSION
​
Location: Annenberg Atrium
8:30 AM Innovation in Urology Research
12:00 PM Concurrent Poster Abstract Presentations
​
​
​
BREAKOUT SESSION I | Decoding the Disease: Biomarkers and Breakthroughs in Prostate Cancer Diagnosis
​
Location: Hatch Auditorium
​
Moderator: Natasha Kyprianou, MBBS, PhD
Panel: Sujit Nair, PhD, Dimple Chakravarty, PhD
Prostatic Acid Phosphatase: A Potential Therapeutic Target in Advanced Prostate Cancer
Alice Levine, MD
10:15am
10:35am
Dissecting the Mechanistic Insights into The Transition from First-Line Castration Resistance to Lineage Plasticity in Prostate Cancer
Goutam Chakraborty, PhD
10:55am
Extracellular Vesicles: Liquid Biopsies for Prostate Cancer Detection
Navneet Dogra, PhD
11:15am
Learning Tumor Biology from Prostate Spatial Transcriptomics Analysis
Alfonso Urbanucci, PhD
11:35am
Unraveling Obesity’s Role in Prostate Cancer: A Gene Network Approach
Zach Dovey, MD
11:55am
Q&A
12:15pm
12:45pm
1:15pm
Lunch Symposium
​
(Lunch served outside Hatch Auditorium, 2nd Floor)
PRESENTATION BEGINS
From Data to Practice: Clinical Results with Hugo™ RAS in Urologic Surgery
(Hatch Auditorium, 2nd Floor)
Sponsored by Medtronic
Not-CME Accredited
​
​
​
​
BREAK
BREAKOUT SESSION II | Defining the Middle Ground: Evidence and Applications of Focal Therapy
​
Location: Hatch Auditorium
Moderator: Michael Gorin, MD
Panel: Avinash Reddy, Michael Gorin, MD, Kyrollis Atalla, MD
1:15pm
Why Cryotherapy is My Preferred Modality for Prostate Ablation
​Michael Gorin, MD
1:30pm
Pushing the Limits of Focal Therapy: How Much Pattern 4 is Acceptable?
Art Rastinehad, DO
1:45pm
Focal Therapy in Prostate Cancer: The Future of Precision Oncology or a Clinical Gamble?
Kyrollis Atallah, MD
BREAKOUT SESSION III | Precision in Sight: MRI, PSMA-PET, and Imaging-Guided Precision
​
Location: Hatch Auditorium
Moderator: Kyrollis Atalla, MD
Panel: Wayne Brisbane, MD,Jim Hu, MD, PhD, Santoshi Nagaonkar, MS, DNB, DNB (Urol), FRACS, FEBU
​
2:05pm
Microultrasound: Avoiding Systematic Biopsy
Wayne Brisbane, MD
2:25pm
AI Applications in Prostate MRI
Bachir Taouli, MD, MHA
2:45pm
Re-establishing the Role of DRE in “MRI-First Pathways”: A Low Cost Biopsy Deferral Real World Validation Model
Santoshi Nagaonkar, MS, DNB, DNB (Urol), FRACS, FEBU
3:05pm
Q&A
3:25pm
BREAK / VISIT EXHIBITS
3:45pm
Imaging-Based Nomograms in Pre-op Planning for Prostatectomy
Alberto Martini, MD
4:05pm
Prediction of ECE with MicroUltrasound
Adriana Pedraza Bermeo, MD
4:20pm
PSMA-PET and Localized Prostate Cancer
Neeraja Tillu, MBBS, MS, MCh
4:35pm
RETURN TO MAIN SESSION FOR CLOSING REMARKS